These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24680087)

  • 1. Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461).
    Sprigg N; Renton CJ; Dineen RA; Kwong Y; Bath PM
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1312-8. PubMed ID: 24680087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Tranexamic Acid Administration on Remote Cerebral Ischemic Lesions in Acute Spontaneous Intracerebral Hemorrhage: A Substudy of a Randomized Clinical Trial.
    Pszczolkowski S; Sprigg N; Woodhouse LJ; Gallagher R; Swienton D; Law ZK; Casado AM; Roberts I; Werring DJ; Al-Shahi Salman R; England TJ; Morgan PS; Bath PM; Dineen RA
    JAMA Neurol; 2022 May; 79(5):468-477. PubMed ID: 35311937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
    Meretoja A; Churilov L; Campbell BC; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM
    Int J Stroke; 2014 Jun; 9(4):519-24. PubMed ID: 23981692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol.
    Jiang C; Wang J; Wang J; Zhang J;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105136. PubMed ID: 32912508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.
    Sprigg N; Robson K; Bath P; Dineen R; Roberts I; Robinson T; Roffe C; Werring D; Al-Shahi Salman R; Pocock S; Duley L; England T; Whynes D; Ciccone A; Laska AC; Christensen H; Ozturk S; Collins R; Bereczki D; Egea-Guerrero JJ; Law ZK; Czlonkowska A; Seiffge D; Beredzie M;
    Int J Stroke; 2016 Aug; 11(6):683-94. PubMed ID: 27048694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.
    Law ZK; Desborough M; Roberts I; Al-Shahi Salman R; England TJ; Werring DJ; Robinson T; Krishnan K; Dineen R; Laska AC; Peters N; Egea-Guerrero JJ; Karlinski M; Christensen H; Roffe C; Bereczki D; Ozturk S; Thanabalan J; Collins R; Beridze M; Bath PM; Sprigg N
    J Am Heart Assoc; 2021 Feb; 10(5):e019130. PubMed ID: 33586453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Christensen H; Ciccone A; Collins R; Czlonkowska A; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Krishnan K; Laska AC; Law ZK; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Seiffge D; Scutt P; Thanabalan J; Werring D; Whynes D; Bath PM;
    Lancet; 2018 May; 391(10135):2107-2115. PubMed ID: 29778325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial.
    Jokar A; Ahmadi K; Salehi T; Sharif-Alhoseini M; Rahimi-Movaghar V
    Chin J Traumatol; 2017 Feb; 20(1):49-51. PubMed ID: 28209450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data From 121 Surgically Treated Participants From the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial.
    Hollingworth M; Woodhouse LJ; Law ZK; Ali A; Krishnan K; Dineen RA; Christensen H; England TJ; Roffe C; Werring D; Peters N; Ciccone A; Robinson T; Członkowska A; Bereczki D; Egea-Guerrero JJ; Ozturk S; Bath PM; Sprigg N;
    Neurosurgery; 2024 Sep; 95(3):605-616. PubMed ID: 38785451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial.
    Yassi N; Zhao H; Churilov L; Campbell BCV; Wu T; Ma H; Cheung A; Kleinig T; Brown H; Choi P; Jeng JS; Ranta A; Wang HK; Cloud GC; Grimley R; Shah D; Spratt N; Cho DY; Mahawish K; Sanders L; Worthington J; Clissold B; Meretoja A; Yogendrakumar V; Ton MD; Dang DP; Phuong NTM; Nguyen HT; Hsu CY; Sharma G; Mitchell PJ; Yan B; Parsons MW; Levi C; Donnan GA; Davis SM
    Stroke Vasc Neurol; 2022 Apr; 7(2):158-165. PubMed ID: 34848566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
    Yassi N; Zhao H; Churilov L; Wu TY; Ma H; Nguyen HT; Cheung A; Meretoja A; Mai DT; Kleinig T; Jeng JS; Choi PMC; Duc PD; Brown H; Ranta A; Spratt N; Cloud GC; Wang HK; Grimley R; Mahawish K; Cho DY; Shah D; Nguyen TMP; Sharma G; Yogendrakumar V; Yan B; Harrison EL; Devlin M; Cordato D; Martinez-Majander N; Strbian D; Thijs V; Sanders LM; Anderson D; Parsons MW; Campbell BCV; Donnan GA; Davis SM;
    Lancet Neurol; 2024 Jun; 23(6):577-587. PubMed ID: 38648814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign.
    Ovesen C; Jakobsen JC; Gluud C; Steiner T; Law Z; Flaherty K; Dineen RA; Christensen LM; Overgaard K; Rasmussen RS; Bath PM; Sprigg N; Christensen H
    Stroke; 2021 Aug; 52(8):2629-2636. PubMed ID: 34000834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic Acid for Adult Patients with Spontaneous Intracerebral Hemorrhage: A Systematic Review with Meta-analysis.
    Wang X; Ma L; Song J; You C
    CNS Drugs; 2021 Nov; 35(11):1163-1172. PubMed ID: 34661872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic Acid Inhibits Hematoma Expansion in Intracerebral Hemorrhage and Traumatic Brain Injury. Does Blood Pressure Play a Potential Role? A Meta-Analysis from Randmized Controlled Trials.
    Gao B; Xue T; Rong X; Yang Y; Wang Z; Chen Z; Wang Z
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105436. PubMed ID: 33171426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial.
    Brown RS; Thwaites BK; Mongan PD
    Anesth Analg; 1997 Nov; 85(5):963-70. PubMed ID: 9356085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial.
    Polymeris AA; Karwacki GM; Siepen BM; Schaedelin S; Tsakiris DA; Stippich C; Guzman R; Nickel CH; Sprigg N; Kägi G; Vehoff J; Barinka F; Thilemann S; Maurer M; Wagner B; Traenka C; Gensicke H; De Marchis GM; Bonati LH; Fischer U; Z'Graggen WJ; Nedeltchev K; Wegener S; Baumgartner P; Engelter ST; Seiffge DJ; Peters N; Lyrer PA;
    Stroke; 2023 Sep; 54(9):2223-2234. PubMed ID: 37466000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: Rationale and design.
    Liu L; Wang Y; Meng X; Li N; Tan Y; Nie X; Liu D; Zhao X;
    Int J Stroke; 2017 Apr; 12(3):326-331. PubMed ID: 28381202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
    Meretoja A; Yassi N; Wu TY; Churilov L; Sibolt G; Jeng JS; Kleinig T; Spratt NJ; Thijs V; Wijeratne T; Cho DY; Shah D; Cloud GC; Phan T; Bladin C; Moey A; Aviv RI; Barras CD; Sharma G; Hsu CY; Ma H; Campbell BCV; Mitchell P; Yan B; Parsons MW; Tiainen M; Curtze S; Strbian D; Tang SC; Harvey J; Levi C; Donnan GA; Davis SM
    Lancet Neurol; 2020 Dec; 19(12):980-987. PubMed ID: 33128912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.